Genzyme raises $141 million for general division
This article was originally published in Clinica
Executive Summary
US healthcare company Genzyme raised $141 million net from the recent offering of nearly 2.9 million shares in its general division priced at $51.25 each. This followed a smaller offering a few weeks earlier of shares in Genzyme's other division, Genzyme Tissue Repair (see Clinica No 676, p 12).